Results 61 to 70 of about 119,784 (210)

C1-inhibitor protects against brain ischemia–reperfusion injury via inhibition of cell recruitment and inflammation

open access: yesNeurobiology of Disease, 2005
Previous studies demonstrated that C1-inhibitor (C1-INH), a complement and contact-kinin systems inhibitor, is neuroprotective in cerebral ischemia.
Claudio Storini   +7 more
doaj   +1 more source

Theoretical Aspects of Molecular Recognition [PDF]

open access: yes, 2009
Molecular recognition is a key process in non-covalent interactions, which determines, among others, host-guest complexation, drug action and protein-protein interaction. A simple and attractive formulation is the lock-and-key analogy defining the host
Harmat, Veronika, Náray-Szabó, Gábor
core   +1 more source

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema [PDF]

open access: yes, 2010
Background We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) and updated this as Hereditary angioedema: a current ...
Tom Bowen   +59 more
core   +3 more sources

Refractory Angioedema in a Patient with Systemic Lupus Erythematosus

open access: yesIranian Journal of Medical Sciences, 2015
Angioedema secondary to C1 inhibitor deficiency has been rarely reported to be associated with systemic lupus erythematosus. A genetic defect of C1 inhibitor produces hereditary angioedema, which is usually presented with cutaneous painless edema, but ...
Zahra Habibagahi   +4 more
doaj  

Proteomic analysis of skin invasion by blood fluke larvae. [PDF]

open access: yes, 2008
BackgroundDuring invasion of human skin by schistosome blood fluke larvae (cercariae), a multicellular organism breaches the epidermis, basement membrane, and dermal barriers of skin.
Braschi, Simon   +7 more
core   +1 more source

Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. [PDF]

open access: yes, 2020
Since 2013, the International Union of Immunological Societies (IUIS) expert committee (EC) on Inborn Errors of Immunity (IEI) has published an updated phenotypic classification of IEI, which accompanies and complements their genotypic classification ...
Ailal, Fatima   +18 more
core  

findings from the Icatibant Outcome Survey [PDF]

open access: yes, 2017
Background Patients with hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) experience recurrent attacks of cutaneous or submucosal edema that may be frequent and severe; prophylactic treatments can be prescribed to prevent attacks ...
Aberer, Werner   +7 more
core   +1 more source

Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies

open access: yesWorld Allergy Organization Journal, 2011
Hereditary angioedema (HAE) caused by C1-esterase inhibitor deficiency is an autosomal-dominant disease resulting from a mutation in the C1-inhibitor gene.
Richard G Gower, MD   +11 more
doaj   +1 more source

Current and Future Therapy of Hereditary Angioedema

open access: yesSouthern Clinics of Istanbul Eurasia, 2020
Hereditary angioedema (HAE) is an autosomal dominant disorder, mostly due to C1 esterase inhibitor (C1-INH) deficiency, known by recurring angioedema attacks that are nonpruritic, not accompanying with urticaria, and involve the dermis, intestinal ...
Öner Özdemir
doaj   +1 more source

Design of New Quinazoline Derivative as EGFR (Epidermal Growth Factor Receptor) Inhibitor through Molecular Docking and Dynamics Simulation

open access: yesIndonesian Journal of Chemistry, 2020
Erlotinib, Afatinib, and WZ4002 are quinazoline derivative compounds and classified as first, second, and third-generation EGFR inhibitor. All inhibitors have been given directly to cancer patients for many years but find some resistance.
Herlina Rasyid   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy